FGF-2 inhibits TNF-α mediated apoptosis through up-regulation of Bcl2-A1 and Bcl-xL in ATDC5 cells |
Kim, Hey-Ryun
(Division of Biochemistry, College of Medicine, Chungbuk National University)
Heo, Youn-Moo (Division of Orthopaedic Surgery, College of Medicine, Chungbuk National University) Jeong, Kyoung-Il (Division of Orthopaedic Surgery, College of Medicine, Chungbuk National University) Kim, Yong-Min (Division of Orthopaedic Surgery, College of Medicine, Chungbuk National University) Jang, Hae-Lan (Division of Medical Infomation and Management, College of Medicine, Chungbuk National University) Lee, Kwang-Yeol (College of Pharmacy, Chonnam National University) Yeo, Chang-Yeol (Department of Life Science and Division of Life and Pharmaceutical Sciences, Ewha Womans University) Kim, Sung-Hoon (Genomic Informatics Center, Hankyong National University) Lee, Hak-Kyo (Genomic Informatics Center, Hankyong National University) Kim, Seung-Ryul (Division of Biochemistry, College of Medicine, Chungbuk National University) Kim, Eung-Gook (Division of Biochemistry, College of Medicine, Chungbuk National University) Choi, Joong-Kook (Division of Biochemistry, College of Medicine, Chungbuk National University) |
1 | Pardo, O. E., Lesay, A., Arcaro, A., Lopes, R., Ng, B. L., Warne, P. H., McNeish, I. A., Tetley, T. D., Lemoine, N. R., Mehmet, H., Seckl, M. J. and Downward, J. (2003) Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells. Mol. Cell Biol. 23, 7600-7610. DOI |
2 | Chia, S. L., Sawaji, Y., Burleigh, A., McLean, C., Inglis, J., Saklatvala, J. and Vincent, T. (2009) Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60, 2019-2027. DOI ScienceOn |
3 | Makino, T., Jinnin, M., Muchemwa, F. C., Fukushima, S., Kogushi-Nishi, H., Moriya, C., Igata, T., Fujisawa, A., Johno, T. and Ihn, H. (2010) Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br. J. Dermatol. 62, 717- 723. |
4 | Sahni, M., Ambrosetti, D. C., Mansukhani, A., Gertner, R., Levy, D. and Basilico, C. (1999) FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13, 1361-1366. DOI ScienceOn |
5 | Krejci, P., Salazar, L., Goodridge, H. S., Kashiwada, T. A., Schibler, M. J., Jelinkova, P., Thompson, L. M. and Wilcox, W. R. (2008) STAT1 and STAT3 do not participate in FGFmediated growth arrest in chondrocytes. J. Cell Sci. 121, 272-281. DOI ScienceOn |
6 | Youle, R. J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59. DOI ScienceOn |
7 | Glaser, R. L., Broman, K. W., Schulman, R. L., Eskenazi, B., Wyrobek, A. J. and Jabs, E. W. (2003) The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutation in sperm. Am. J. Hum. Genet. 73, 939-947. DOI ScienceOn |
8 | Goriely, A., McVean, G. A., Rojmyr, M., Ingemarsson, B. and Wilkie, A. O. (2003) Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301, 643. DOI ScienceOn |
9 | Feldman, B., Poueymirou, W., Papaioannou, V. E., DeChiara, T. M. and Goldfarb, M. (1995) Requirement of FGF-4 for postimplantation mouse development. Science 267, 246- 249. DOI ScienceOn |
10 | Vogler, M., Dickens, D., Dyer, M. J., Owen, A., Pirmohamed M. and Cohen G. M. (2011) The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. Biochem. Biophys. Res. Commun. 408, 344-349. DOI ScienceOn |
11 | Lee, H. H., Dempsey, P. W., Parks, T. P., Zhu, X., Baltimore, D. and Cheng, G. (1999) Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NFkappaB activation and intercellular adhesion molecule-1 up-regulation. Proc. Natl. Acad. Sci. U.S.A 96, 1421-1426. DOI |
12 | Duriez, P. J., Wong, F., Dorovini-Zis, K., Shahidi, R. and Karsan, A. (2000) A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J. Biol. Chem. 275, 18099-18107. DOI ScienceOn |
13 | Karsan, A., Yee, E. and Harlan, J. M. (1996) Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271, 27201-27204. DOI ScienceOn |
14 | Wang, C. Y., Guttridge, D. C., Mayo, M. W. and Baldwin, A. S. Jr. (1999) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy- induced apoptosis. Mol. Cell Biol. 19, 5923-5929. DOI |
15 | Rastegar, F., Gao, J. L., Shenag, D., Luo, Q., Shi, Q., Kim, S. H., Jiang, W., Wagner, E. R., Huang, E., Gao, Y., Shen, J., Yang, K., He, B. C., Chen, L., Zuo, G. W., Luo, G. W., Luo, J., Luo, X., Bi, Y., Liu, X., Li, M., Hu, N., Wang, L., Luther, G., Luu, H. H., Haydon, R. C. and He, T. C. (2010) Lysophosphatidic acid acyltransferase (LPAAT ) promotes the tumor growth of human osteosarcoma. PLoS One 5, e14182. DOI ScienceOn |
16 | Lin, E. Y., Orlofsky, A., Berger, M. S. and Prystowsky, M. B. (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151, 1979-1988. |
17 | Cross, A., Moots, R. J. and Edwards, S. (2008) The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. Blood 111, 878-884. DOI ScienceOn |
18 | Reers, M., Smith, T. W. and Chen, L. B. (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 7, 4480- 4486. |
19 | Tare, B. S., Howard, D., Pound, J. C., Roach, H. I. and Oreffo, R. O. C. (2005) ATDC5: an ideal cell line for development of tissue engineering strategies aimed at cartilage generation. Eur. Cell. Mater. 10(Suppl 2), 22. |
20 | Im, Y. S., Shin, H. K., Kim, H. R., Jeong, S. H., Kim, S. R., Kim, Y. M., Lee, D. H., Jeon, S. H., Lee, H. W. and Choi, J. K. (2009) Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1. Mol. Cells 28, 119-124. DOI ScienceOn |
21 | Shirane, M. and Nakayama, K. I. (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol. 5, 28-37. DOI ScienceOn |
22 | Choi, B. H., Feng, L. and Yoon, H. S. (2010) FKBP38 protects Bcl-2 from caspase-dependent degradation. J. Biol. Chem. 285, 9770-9779. DOI ScienceOn |
23 | Fiebig, A. A., Zhu, W., Hollerbach, C., Leber, B. and Andrews, D. W. (2006) Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer 6, 213. DOI |
24 | Colvin, J. S., White, A. C., Pratt, S. J. and Ornitz, D. M. (2001) Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128, 2095. |
25 | McIntosh, I., Bellus, G. A. and Jab, E. W. (2000) The pleiotropic effects of fibroblast growth factor receptors in mammalian development. Cell Struct. Funct. 25, 85-96. DOI ScienceOn |